XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net (loss) income attributable to common stockholders $ (16,474) $ 6,494 $ (2,179)
Adjustments to reconcile net loss (income) attributable to common stockholders to net cash used in operating activities:      
Depreciation and amortization and amortization of deferred finance costs 3,998 2,970 2,977
Stock-based compensation expense 530 806 905
Gain on sale of school condominium 0 (24,196) 0
Gain on sale of residential condominiums, net (321) 0 0
Gain on sale of real estate 0 0 (9,521)
Deferred rents receivable (24) (84) 578
Other non-cash adjustments - pension expense 816 1,015 1,992
Unrealized gain on warrants (73) (965) 0
Equity in net loss from unconsolidated joint ventures 555 1,571 819
Distribution from unconsolidated joint ventures 885 1,110 33
Decrease (increase) in operating assets:      
Receivables 882 2,392 1,577
Prepaid expenses and other assets, net (257) 190 278
Increase (decrease) in operating liabilities:      
Accounts payable and accrued expenses 3,467 (686) 1,649
Pension liabilities (1,288) (1,033) (2,705)
Net cash used in operating activities (7,304) (10,416) (3,597)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Additions to real estate (36,349) (51,715) (91,847)
Net proceeds from sale of real estate 22,275 0 18,812
Deferred real estate deposits of condominiums 0 1,971 33,609
Investments in unconsolidated joint ventures 0 (5,383) 0
Net cash used in investing activities (14,074) (55,127) (39,426)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from loans and corporate credit facility 249,984 86,361 55,475
Proceeds from secured line of credit 8,200 5,000 7,250
Payment of finance costs (6,552) (1,497) (1,531)
Repayment of loan (225,547) (23,368) (10,557)
Repayment of secured line of credit (3,200) (2,500) (2,000)
Settlement of stock awards (370) (695) (772)
Stock buy-back 0 (359) (197)
Sale of common stock, net 7,639 0 0
Net cash provided by financing activities 30,154 62,942 47,668
NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH 8,776 (2,601) 4,645
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD 16,069 18,670 14,025
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD 24,845 16,069 18,670
CASH AND CASH EQUIVALENTS, BEGINNING PERIOD 6,515 9,196 11,496
RESTRICTED CASH, BEGINNING OF PERIOD 9,554 9,474 2,529
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD 16,069 18,670 14,025
CASH AND CASH EQUIVALENTS, END OF PERIOD 4,310 6,515 9,196
RESTRICTED CASH, END OF PERIOD 20,535 9,554 9,474
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD 24,845 16,069 18,670
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:      
Cash paid during the period for: Interest 16,042 15,495 12,631
Cash paid during the period for: Taxes 395 251 352
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:      
Accrued development costs included in accounts payable and accrued expenses 8,805 10,319 12,698
Capitalized amortization of deferred financing costs and warrants 3,580 2,727 2,737
Capitalized stock-based compensation expense 177 356 480
Loan forgiveness 243 0 0
Investment in unconsolidated joint venture 0 5,193 0
Right-of-use asset 0 0 (1,904)
Lease liabilities 0 0 (2,065)
Warrant liability $ 0 $ 0 $ 1,795